Rocket Lab's Neutron Debut Slips to 2027 After Tank-Dome Rework, and the Street Is Split on What the Wait Is Worth

Rocket Lab's routine business of launching small satellites is humming along. Its next big bet is not. On Wednesday, an Electron rocket is scheduled to lift off from Launch Complex 1 in New Zealand carrying three satellites for HawkEye 360 on a mission dubbed "We're Not Hawking Around" — the kind of steady, repeatable cadence the company has built its reputation on. Yet the stock is trading well below its highs, and the reason has nothing to do with the workhorse Electron and everything to do with the rocket that is supposed to take Rocket Lab into the heavy-lift league.

The Neutron's first flight has been pushed from the fourth quarter of 2026 into 2027. The culprit: air pockets that appeared during manufacturing of the fuel-tank domes on the first stage. Rocket Lab says it has identified the root cause and added extra production steps to prevent a recurrence, a fix CEO Peter Beck has confirmed. The extra work, however, absorbs resources and pushes the first commercial revenue from the new vehicle further into the future.

A familiar rhythm, and its limits

The Electron side of the house keeps delivering. Missions such as the transport of a StriX satellite for Japanese Earth-observation firm Synspective — already the twelfth launch for that customer — have cemented the small rocket as a fixture in the market. Commercial customers value the dependable frequency of orbital transport. That same routine, though, marks the segment's ceiling: small launchers serve specialized niches, while the larger addressable market and heavier payloads only open up with bigger vehicles. Getting there is precisely what the Neutron program is for.

The market marks it down

Investors have registered the schedule change sharply. The shares closed at €45.85 on the prior session, and over the past seven days the stock has shed 20%, leaving it 66% below its 52-week high. In German trading today the price stood at €45.05, a daily loss of 1.7%, extending the softer tone that followed the delay announcement. The drop illustrates the valuation discount that capital-intensive space projects attract when timelines slip.

Two houses, two verdicts

Wall Street's reaction has been anything but uniform. Goldman Sachs moved cautiously on Thursday, trimming its price target to $67 from $75 while keeping a "Neutral" rating, citing added expenses and an expected rise in cash burn. Citizens was more aggressive on the downside but stayed constructive on the stock: analyst Trevor Walsh cut his target to $90 from $130 on Friday yet maintained a "Market Outperform" rating, pointing to the shifted timing of future launch monetization.

Not everyone flinched. A clutch of research houses left their buy recommendations untouched, with targets ranging from $90 to $132, treating the rework as an ordinary part of developing a heavy-lift rocket rather than a threat to the program's long-term value. Morgan Stanley, according to media reports, reaffirmed its "Buy" rating on October 16 with a $105 target.

The bill for the wait

For shareholders, the delay narrows the window in which Rocket Lab can break into the medium- and heavy-payload market. A longer development phase temporarily raises the company's capital needs. At the same time, the refined production method gives Rocket Lab a chance to avoid later launch failures caused by undetected material weaknesses. Whether that reassures investors over the long haul will depend on how the qualification tests for Neutron's components unfold — and on whether the Electron keeps flying on schedule while the bigger rocket catches up.